Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marcet A. An essay on the chemical history and medical treatment of calculous disorders. London: Longman, Hurst, Rees, Orme, and Brown; 1817.
Prien EL, Frondel C. Studies in urolithiasis: I. The composition of urinary calculi. J Urol. 1947;57:949–91.
Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol. 2005;173(3): 848–57.
White DJ, Nancollas GH. Triamterene and renal stone formation: the influence of triamterene and triamterene stones on calcium oxalate crystallization. Calcif Tissue Int. 1987;40(2):79–84.
Watson RA, Ettinger B, Deshon Jr GE, Agee RE, Oldroyd NO. Triamterene stone: advantage of crystallographic analysis. Urology. 1981;18(3):238–40.
Farrer JH, Rajfer J. Silicate urolithiasis. J Urol. 1984;132(4):739–40.
Lee MH, Lee YH, Hsu TH, Chen MT, Chang LS. Silica stone- development due to long time oral trisilicate intake. Scand J Urol Nephrol. 1993;27(2):267–9.
Albala DM, Prien Jr EL, Galal HA. Urolithiasis as a hazard of sulfonamide therapy. J Endourol. 1994;8(6): 401–3.
Scudi JV, Silber RH. Urinary excretion products of sulfaquinoxaline. J Biol Chem. 1944;156:343–8.
Scudi JV, Jelinek VC. A distribution method for the differentiation of urinary excretion products of the sulfonamide drugs and the role of these products in urolithiasis. J Pharmacol Exp Ther. 1944;81(3):218–23.
Schwartz BF, Schenkman N, Armenakas NA, Stoller ML. Imaging characteristics of indinavir calculi. J Urol. 1999;161(4):1085–7.
Gentle DL, Stoller ML, Jarrett TW, Ward JF, Geib KS, Wood AF. Protease inhibitor-induced urolithiasis. Urology. 1997;50(4):508–11.
Matlaga BR, Shah OD, Assimos DG. Drug-induced urinary calculi. Rev Urol. 2003;5(4):227–31.
Mulvaney WP, Beck CW, Brown RR. Urinary phenazopyridine stones. JAMA. 1972;221(13):1511–2.
Simmonds HA. 2,8-Dihydroxyadenine lithiasis. Clin Chim Acta. 1986;160(2):103–8.
Klineberg JR, Goldfinger SE, Seegmiller JE. The effectiveness of the xanthine oxidase inhibitor allopurinol in the treatment of gout. Ann Intern Med. 1965;62:639–47.
Strauven P, Hesse A, Thon A, Behrendt H. Xanthinuria with nephrolithiasis in infancy. Akt Urol. 1989;20: 218–22.
Diven SC. Xanthinuria. http://www.author.emedicine.com/PED/topic2452.htm
Volpe P, Peyrottes A, Lammle M, Saquet D, Choquenet C. Xanthine urinary calculus in a patient with Lesch-Nyhan syndrome. Apropos of a case. Prog Urol. 1997;7:74–7.
Potter JL, Silvidi AA. Xanthine lithiasis, nephrocalcinosis, and renal failure in a leukemia patient treated with allopurinol. Clin Chem. 1987;33:2314–6.
Simmonds HA. 2,8-dihydroxyadenine lithiasis. Clin Chem Acta. 1986;160:103–8.
Witten FR, Morgan JW, Foster JG, Glenn JF. 2,8-dihydroxyadenine urolithiasis: review of the literature and report of a case in the United States. J Urol. 1983;130:938–42.
Kelley WN, Levy RI, Rosenbloom FM, Henderson JF, Seegmiller JE. Adenine phosphoribosyltransferase deficiency: a previously undescribed genetic defect in man. J Clin Invest. 1968;47(10):2281–9.
Lamontagne Jr AE. 2,8-dihydroxyadenine urolithiasis: report of a case in a woman in the United States. J Urol. 1989;142(2 pt 1):369–70.
Usenius JP, Ruopuro ML, Usenius R. Adenine phosphoribosyltransferase deficiency: 2,8-dihydroxyadenine urolithiasis in a 48-year-old woman. Br J Urol. 1988;62(6):521–4.
Greenwood MC, Dillon MJ, Simmonds HA, Barratt TM, Pincott JR, Metreweli C. Renal failure due to 2,8-dihydroxyadenine urolithiasis. Eur J Pediatr. 1982;138(4):346–9.
Yagisawa T, Yamazaki Y, Toma H, Kamatani N. Radiopaque 2,8-dihyroxyadenine lithiasis. Int Urol Nephrol. 1999;31:141–33.
Glicklich D, Gruber HE, Matas AJ, Tellis VA, Karwa G, Finley K, Salem C, Soberman R, Seegmiller JE. 2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant. Q J Med. 1988;68:785–93.
Futcher TB. Dr. Osler’s renal stones. Arch Int Med. 1949;84(1):40.
Bliss M. William Osler: a life in medicine. Oxford: Oxford University Press; 1999.
Osler W. The principles and practice of medicine. New York, NY: Appleton & Co; 1892. p. 766.
Moran ME, Das S, Rosenberg SA. Sir William Osler's perceptions of urolithiasis and the case of the indigo calculus. J Endourol. 2005;19(10):1157–60.
Nation EF. William Osler on penis captivus and other urologic topics. Urology. 1973;11:468–70.
Tigertt WD. An annotated life of Egerton Yorrick Davis, MD, an intimate of Sir William Osler. J Hist Med Allied Sci. 1983;38:259–97.
Cushing H. The life of Sir William Osler, vol. 2. Oxford: Oxford, Clareden Press; 1925.
Eisendrath DN, Rolnick HC. Text-book of urology for students and practitioners. Philadelphia, PA: J. B. Lippincott; 1928.
Winsbury-White HP. Stone in the urinary tract. London: Churchill; 1929.
Pfister E. Uber blaue Indigokristalle in agyptischen Blasensteinen. Zeits Urol. 1916:329–41.
Koppeschaar WP. The estimation of indigo blue and indigo red in natural and synthetic indigos. Chem News. 1900;81–82:37.
Blue Urine. Lancet. 1901:1535.
Carter TA. Notes of two cases in which the urine yielded indigo. Med Chir Soc Edinburgh. 1858;July:85–6.
Carter TA. On indican in the blood and urine. Edin Med J. 1859;June:119–29.
Montgomery GN. A case of indicanuria. Lancet. 1908;6:1621.
Ord WM. A calculus largely composed of indigo. Br Med J. 1878;2(917):132–4.
Hawk PB. Practical physiological chemistry. Philadelphia, PA: P. Blakiston’s Sons & Co; 1907. p. 343.
Forbes WS. Indigo calculus from the kidney. Med News. 1894;65:187–8.
Golden RL. A history of William Osler’s the principles and practice of medicine. Montreal: Osler Library, McGill University; 2004.
Fairbanks VF. Blue gods, blue oil, and blue people. Mayo Clin Proc. 1994;69:889–92.
The Nobel prize for chemistry. 1905: Adolf von Baeyer. http:/www.nobel.se/chemistry/laureates/1905/baeyer-bio.html
Ellis JJ. Founding brothers the revolutionary generation. New York, NY: Vintage Books; 2000. p. 18.
Golden RL. William Osler, urolithiasis, and god’s own medicine. Urology. 2009;74(3):517–21.
Barondess JA. A case of empyema: notes on the last illness of Sir William Osler. Trans Am Clin Climatol Assoc. 1975;86:59–72.
Arnold WN. King george III’s urine and indigo blue. Lancet. 1996;347(9018):1811–3.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Moran, M.E. (2014). The Rarest Stone of All!. In: Urolithiasis. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8196-6_26
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8196-6_26
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8195-9
Online ISBN: 978-1-4614-8196-6
eBook Packages: MedicineMedicine (R0)